结肠直肠癌中的河马信号通路:通过各种信号和治疗潜力的调制
Somayeh Mohammadpour1, Amir Torshizi Esfahani1, SeyedKasra Sarpash2
1Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
结肠直肠癌 (CRC) 治疗耐药性需要了解瘤生物学. 河马通路对于CRC的发病和进展至关重要,它提供了潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 结肠直肠癌 (CRC) 是一个重大的全球健康挑战,发病率和死亡率很高.
- 化疗和放射治疗等现有治疗方法经常面临CRC细胞的抵抗.
- 了解瘤的形成,攻击性,转移和治疗耐药性对于改善结果至关重要.
研究的目的:
- 阐明Hippo通路在结直肠癌 (CRC) 中的作用和调节.
- 探索Hippo通路与其他信号通路,非编码RNA,肠道微生物群和CRC中的免疫微环境的相互作用.
- 确定针对CRC中的Hippo信号功能障碍的新型治疗策略.
主要方法:
- 这篇评论综合了目前关于河马通路在CRC中的参与的研究.
- 它检查了CRC中的基因突变和Hippo途径组件的改变表达.
- 该评论分析了Hippo途径和其他与CRC相关的生物因素之间的相互作用.
主要成果:
- 河马通路在CRC中经常被破坏,导致瘤发生和进展.
- 河马通路的失调与CRC的攻击性和治疗耐药性有关.
- 准Hippo通路调节器为新型CRC疗法提供了一个有希望的途径.
结论:
- 河马通路是CRC发展和进展的关键参与者.
- 调节河马通路,结合了解其相互作用,为CRC提供了创新的治疗潜力.
- 对Hippo通路信号的进一步研究对于推进CRC治疗方法至关重要.
更多相关视频
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
相关概念视频
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Non-Canonical Wnt Signaling Pathways
